| PKNOX2 |
gene |
4 |
3 |
PBX/Knotted 1 Homeobox 2 |
| placebo beverage |
drug |
5 |
3 |
beverage with 3 ml ethanol floated, placebo |
| placebo group |
cohort |
4 |
1 |
PLA PG, placebo, placebo group, placebo participants |
| placebo participants |
cohort |
2 |
1 |
|
| place preference |
phenotype |
4 |
2 |
conditioned place preference, ethanol-mediated place preference |
| planning |
phenotype |
8 |
5 |
planning |
| plaque |
phenotype |
2 |
1 |
amyloid plaque, plaques |
| plasmids |
drug |
3 |
— |
|
| Play behavior |
phenotype |
4 |
3 |
play |
| Plcb1 |
gene |
3 |
2 |
PLCβ, Plcb1 |
| PLCL1 |
gene |
3 |
2 |
phospholipase C-like 1 |
| PLCO |
cohort |
3 |
2 |
PLCO participants, Prostate Lung Colorectal Ovarian Cancer Screening Trial, Prostate Lung Colorectal and Ovarian Cancer Screening Trial, Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial |
| pleasurable response to smoking |
phenotype |
2 |
2 |
|
| pleasure |
phenotype |
4 |
3 |
|
| Plink |
drug |
17 |
6 |
PLINK software, PLINK17 |
| PLP1 |
gene |
5 |
4 |
myelin proteolipid protein 1, proteolipid protein 1 |
| pluripotency |
phenotype |
5 |
3 |
|
| pluripotent cells |
drug |
2 |
2 |
|
| PMBB |
cohort |
2 |
2 |
|
| PMI |
phenotype |
4 |
2 |
Postmortem interval, postmortem interval |
